sciencedaily.com / .sciencedaily-com / Page 4

Forever chemicals' are everywhere. But only a handful have been evaluated for potentially toxic effects. Researchers think there may be a faster, cheaper way to figure out which ones might be hazardous to our health -- using worms.

Those who suffer myasthenia gravis experience muscle weakness that can affect the muscles we use to blink, smile and move our bodies. Researchers used a cutting-edge imaging technique to uncover new details about the mechanisms underlying the disease ...

A collaborative study found that while sleep duration recovers quickly, sleep timing and sleep architecture can take significantly longer to realign when traveling across time zones.

Titanium micro-particles in the oral mucosa around dental implants are common. This is shown in a new study which also identified 14 genes that may be affected by these particles.

Shifting cultural perceptions of beauty could drive 'lip dysmorphia', so psychologists tested the response of 32 people to altered images of lips to see how they responded. The results were surprising.

Nanoplastics are an increasing threat to the ecosystem; however, their mobility in the soil is still underexplored. Against this backdrop, researchers investigated the adsorption and aggregation behavior of nanoplastics in different types of soil ...

FLUID, an open-source, 3D-printed robot, offers an affordable and customizable solution for automated material synthesis, making advanced research accessible to more scientists.

Researchers analyzed trade-related risks to energy security across 1,092 scenarios for cutting carbon emissions by 2060. They found that swapping out dependence on imported fossil fuels for increased dependence on critical minerals for clean energy . ...

Researchers have discovered a new way that neurons act in neurodegeneration by using human neural organoids -- also known as 'mini-brain' models -- from patients with frontotemporal lobar degeneration (FTLD). Understanding this new pathway could help ...

Researchers have discovered that 'DEAD-box helicases 54 (DDX54)', a type of RNA-binding protein, is the master regulator that hinders the effectiveness of immunotherapy -- opening a new path for lung cancer treatment.